Big Gain For Rubius Therapeutics, Inc.

Fri, Sep 02, 2022 at 07:20 PM
Big Gain For Rubius Therapeutics, Inc.

Rubius Therapeutics, Inc. (RUBY:NASDAQ) jumped higher at $0.93, representing a gain of 23.4%. On Fri, Sep 02, 2022, RUBY:NASDAQ touched a New 2-Week High of $0.93. The stock appeared on our News Catalysts scanner on Tue, Aug 09, 2022 at 10:38 AM in the 'INVESTOR UPDATE' category. From Fri, Aug 19, 2022, the stock recorded 50.00% Up Days and 36.36% Green Days

The stock spiked on Wed, Jun 08, 2022 at $1.57 with a volume of 4M+.

About Rubius Therapeutics, Inc. (RUBY:NASDAQ)

Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.